Tracy is a member of Lilly’s Diabetes and Obesity Corporate Affairs team. They have made a significant impact in increasing access to evidence-based comprehensive obesity care. The team has helped reduce obesity related bias and stigma by engaging the policy community on the importance of person-first language, bias-free imagery, and achieving obesity care access parity.

Justin is the site lead of Pfizer’s St. Louis, MO office. For the last 15 years, Justin and his team have furthered the understanding of novel biotherapeutics, gene therapies, and vaccines within Pfizer’s R&D organization. There, he has hosted external partners to explain the vital role R&D plays in the biopharmaceutical industry.

Kimberly serves as the project lead for GSK’s Inflation Reduction Act Planning and Implementation team, making her the single point of accountability. She coordinates GSK’s efforts to adapt to the law’s provisions and ensures the IRA’s impact is included in strategic and operating assessments. Kimberly also engages with government agencies and other groups to discuss

Helen has helped build UCB’s external community-giving approach. She has long-term relationships with STEM organizations like BioBuilder, as well as organizations doing STEM work, like the Girl Scouts. She organizes service projects for UCB’s Atlanta employees and she even spent her volunteer days on a health mission trip in Honduras.

Dr. Wahdan advocates for advancing the health of women through science, research and accessible treatment options. Over the past few years, she has become a valued partner of Bayer’s Government Affairs team. She plays a vital role in engaging stakeholders and policymakers at every level of government on the changing landscape in women’s health care.